INTRODUCTION
Ins(1,4,5)P3 (InsP3) is a second messenger responsible for the mobilization of intracellular Cal' (Berridge and Irvine, 1989) .
The InsP3 signal can be inactivated by two pathways: it is either dephosphorylated by an InsP3 5-phosphatase to produce Ins(1,4)P2 or phosphorylated by an InsP3 3-kinase to yield Ins(1,3,4,5)P4 (InsP4) (Irvine et al., 1986; Erneux and Takazawa, 1991) . InsP4 may itself regulate intracellular Ca 2 concentration by promoting Cal' sequestration in rat liver cells (Hill et al., 1988) or by synergizing with InsP, to mobilize intracellular Ca 2 stores in mouse lacrimal acinar cells (Morris et al., 1987) . Other studies in endothelial cells provide direct evidence for a distinct second-messenger function of InsP4 alone in the uptake of Ca 2 (Liickhoff and Clapham, 1992) . The presence of specific InsP4-binding sites in a number of tissues further supports a role for InsP4 in the phosphoinositide pathway (Reiser et al., 1991; Theibert et al., 1991; Cullen and Irvine, 1992; Cullen et al., 1994 ). An inositol polyphosphate receptor has been purified from bovine cerebellum. When reconstituted into planar bilayers, it displays K+-channel activity, which is selectively modulated by InsP4 (Chadwick et al., 1992) .
InsP3 acts as a second messenger by specific binding to its intracellular receptors. InsP3 receptor (type I) was originally cloned from mouse (Furuichi et al., 1989) , rat (Mignery et al., 1990) and later from human (Sudhof et al., 1991) . Various different forms of the receptor product from an alternatively spliced gene or encoded by different genes have been reported Sudhof et al., 1991; Ross et al., 1992) . Two cDNAs encoding two isoenzymes of InsP3 3-kinase (i.e. InsP3 3-kinase A and B) have been isolated from a human hippocampus cDNA library (Takazawa et al., 1991a, b) . These isoenzymes appeared to be composed of a catalytic domain and a region involved in regulation of activity. The C-terminal part of human InsP3 3-kinase B (residues 187-462) was 68 % identical with the C-terminal part of human InsP3 3-kinase A (residues 178-455) and has been shown to correspond to the catalytic domain Communi et al., 1993) . They differed, however, in their molecular mass and sensitivity to Ca2/calmodulin (CaM) . Moreover, the human platelet InsP3 3-3-kinase A probe hybridized to a 2 kb mRNA only in brain and a 1.8-2.0 kb mRNA species in testis. Northern-blot analysis of three human cell lines probed with a human InsP3 3-kinase B probe showed the presence of a 6 kb mRNA in all cell lines, except in the human neuroblastoma cell line (SH-SY5Y), where two mRNA species of 5.7 and 6 kb were detected. Using the same blot, no hybridization signal could be seen with a human InsP3 3-kinase A probe. Altogether, our data are consistent with the notion that the two InsP3 3-kinase isoenzymes, A and B, are specifically expressed in different tissues and cells. kinase was not recognized by immunodetection with anti-(human InsP3 3-kinase A) or anti-(human InsP3 3-kinase B) antibodies, suggesting the existence of another InsP3 3-kinase isoenzyme 
MATERIALS AND METHODS Materials
SH-SY5Y human neuroblastoma-cell monolayers (passages 70-90) were kindly provided by Dr. R. A. Wilcox (Department of Cell Physiology and Pharmacology, University of Leicester, Leicester, U.K.). The human non-differentiated promyelocyticleukaemia-cell line (HL-60) and the human glioma-cell line (HTB-138, from left temporal lobe) were obtained from the American Type Culture Collection. Cell-culture media were from Gibco Life Technologies (U.K). Materials for enzymic assay were as previously reported (Takazawa et al., 1988 
Analytical procedures
InsP3 3-kinase activity was measured in 50,ul of incubation medium as previously reported . Soluble fractions of rat tissues were prepared as outlined by Takazawa et al. (1988) . Protein content was measured as described by Petersen (1977 Cloning of rat and human lnsP3 3-kinase B Recombinant phages (5 x 105) from a rat thymus cDNA library (Stratagene) were screened using a 1048 bp Pstl--PstI restriction fragment of the clone hh3 MB1 (Takazawa et al., 1991b Figure 2 (below).
InsP3 3-kinase activity of both EB15 and hvl R was expressed as previously described. A 5 ml portion of Luria-Bertani ('LB') medium containing 50 ,tg/ml ampicillin was inoculated overnight at 37°C with the appropriate plasmid; the bacterial lysate was made up in 0.5 ml (Takazawa et al., 1991b) .
Cell culture SH-SY5Y cells were cultured in minimum essential medium supplemented with 10 % (v/v) heat-inactivated foetal-calf serum, penicillin (100 units/ml), streptomycin (100flg/ml), fungizone (5 ,g/ml) and 2 mM glutamine (Lambert et al., 1991) . HL-60 cells were cultured in RPMI medium supplemented with 10%
(v/v) heat-inactivated foetal-calf serum, penicillin (50 units/ml), streptomycin (50 ,ug/ml) and 5 mM glutamine (Bradford et al., 1992) . HTB-138 cells were cultured in Dulbecco's modification of Eagle's medium with 4.5 g/l glucose and supplemented with 100% (v/v) heat-inactivated foetal-calf serum, penicillin (50 units/ml), streptomycin (50 ,tg/ml) and 1 mM sodium pyruvate, according to the culture conditions described by the American Type Culture Collection.
Total RNA extraction From cells Confluent cells were scraped from four 100 mm dishes in 1.9 ml of 4 M guanidinium monothiocyanate (Chirgwin et al., 1979) . After the addition of 840 mg of CsCl to this homogenate, each sample was layered on the top of a 1.2 ml cushion of 5.7 M CsCl in 0.1 M EDTA. Separation of total RNA was made after centrifugation at 15°C for 17 h at 35000 rev./min in a Beckman SW55 rotor. The RNA was treated with proteinase K (60 /tg/ml) in 0.3 M NaCl/1 % SDS. After two standard phenol extractions, the total amount of RNA was determined spectrophotometrically (A260). The ratio A260/A280 was verified and was always more than 1.8.
From tissues
Approx. 1.5 g of tissue was homogenized in 20 ml of 4 M guanidinium monothiocyanate. After the addition of 8 g of CsCl to this homogenate, each sample was layered on the top of a 12.6 ml cushion of 5.7 M CsCl in 0.1 M EDTA. Separation of total RNA was made after centrifugation at 15°C for 24 h at 25000 rev./min in a Beckman SW28 rotor. The RNA was prepared as described above.
The yield of total RNA was consistently 300-500 /tg/g of tissue and 200-300 ,ug/four dishes of confluent cells.
The RNA quality was assayed spectrophotometrically and by agarose-gel electrophoresis. The gel was stained with ethidium bromide (10 ,tg/ml), and the staining intensity of the ribosomal RNA visually inspected.
Poly(A) mRNA purffication Poly(A) mRNA from cells or tissues was isolated by using PolyATtract mRNA Isolation System III (Promega). A 500,ug portion of total RNA was used for each poly(A) mRNA purification to obtain between S and 14 jtg of each poly(A) 
RESULTS
Molecular cloning and expression of rat thymus and human hippocampus lnsP3 3-kinase B
An alignment of both rat and human InsP3 3-kinase B amino acid sequences is shown in Figure 1 . A rat thymus cDNA library was screened with a human InsP3 3-kinase B cDNA probe (clone Figure 2 ) versus (G/A)CCATGG (Kozak, 1986) . InsP3 3-kinase activity of hvl R at 10 ,uM InsP3 was I1 nmol/min per ml and was stimulated 4-7-fold by Ca2+/CaM.
From the cDNA sequence analysis, the 5' end (positions (c) Figure 3 Northern-blot analysis of total RNA and poly(A) mRNA from various rat tissues (a) Northern-blot analysis using an a-32P-labelled cDNA probe synthesized using the 550 bp EcoRl-Hincll-restriction-endonuclease fragment of clone CP16 (see Figure 2 ). The sizes of transcripts encoding the rat InsP3 3-kinase A were 2 kb in brain and 1.8-2.0 kb in testis (indicated by arrowheads). (b) Northern-blot analysis using an a-32P-labelled cDNA probe synthesized using the 517 bp BamHI-BamHl-restriction-endonuclease fragment of clone EB15 (see Figure 2 ). Northern-blot analysis of total RNA and poly(A) mRNA preparations from various rat tissues identified the mRNA for rat InsP3 3-kinase A as a 2 kb transcript in brain and as a doublet of 1.8-2.0 kb in testis (Figure 3a) . The minor 4 kb message seen in testis is probably an artefact, as it was not reproduced in four independent Northern blots. In all other tissues examined (i.e. thymus, spleen, liver, kidney, heart, lung and intestine), no hybridization signal was observed. We verified that all tissues had InsP3 3-kinase activity (Table 1) .
The expression of rat InsP3 3-kinase B mRNA was studied with a BamHI-BamHI probe (i.e. 517 bp) derived from clone EBl 5 (Figure 2) . The same blot which was hybridized with a rat InsP3 3-kinase A probe was used for hybridization with a rat InsP3 3-kinase B probe: a 6 kb transcript was detected predominantly in lung, but also in thymus, testis, brain and heart (Figure 3b) .
The presence of RNA was verified by ethidium bromide staining of the same RNA in a parallel lane and by hybridization of the same blot with a GAPDH probe (Figure 3c ).
Northern-blot analysis of lnsP3 3-kinase A and B isoenzymes in human cell lines
In all cell lines studied, InsP3 3-kinase activity could be measured. At M InsP3, 0.1 lM CaM and 1O uM free Ca2+, enzyme activity ranged between 0.5 and 0.8 nmol/min per mg of protein.
Northern-blot analysis was performed using total RNA and poly(A) mRNA prepared from three human cell lines (SH-SYSY, HL-60 and HTB-138). Rat thymus, testis and brain total RNA and poly(A) mRNA were run on the same gel and used as internal controls. The nucleotide identity between rat and human InsP3 kinase A probes was 87 . It is only 61 % between rat and human InsP3 kinase B probes. Specific probes were designed to the 5' end of the coding region of the human InsP3 3-kinase A and B: for the isoenzyme A, the probe was an EcoRI-NcoI fragment from the hh39 clone (526 bp) and for the isoenzyune B, we designed a PstI-Pstl fragment of 588 bp from the hvl R clone, as shown in Figure 2 . Using a human InsP3 3-kinase A probe, no hybridization signal was seen in any cell line; in contrast, the expression of rat brain and testis mRNA species, respectively 2 and 1.8-2.0 kb signals, were detected with the same probe (Figure 4a) or with a rat InsP3 3-kinase A probe (Figure 4b ). The high similarity between both probes (87 % in terms of nucleic acid) probably explains this cross-hybridization.
The expression pattern of human InsP3 3-kinase B is shown in Figure 4(c) ; the human InsP3 3-kinase B probe hybridized with Figure 4 Northern-blot analysis of total RNA and poly(A) mRNA from human cell lines and rat tissues (a) Northern-blot analysis using an c-32P-labelled cDNA probe synthesized using the 526 bp EcoRl-Ncol-restriction-endonuclease fragment of clone hh39 (see Figure 2) . No hybridization signal is observed in human cells. (b) Northern-blot analysis using an cz-32P-labelled cDNA probe synthesized using the 550 bp EcoRl-Hincll-restriction-endonuclease fragment of clone CP16 (see Figure 2) . The sizes of transcripts encoding the rat InsP3 3-kinase A were 2 kb in brain and 1.8-2.0 kb in testis (indicated by arrowheadheads). (c) Northern-blot analysis using an a-32P-labelled cDNA probe synthesized using the 588 bp Pstl-Pstl-restriction-endonuclease fragment of hvl R (see Figure 2) . The sizes of transcripts encoding the human InsP3 3-kinase B were 6 kb in HL-60 and HTB-138 and 5.74.0 kb in SH-SY5Y (indicated by arrows). (d) Northern-blot analysis using an a-32P-labelled cDNA probe synthesized using the 517 bp BamHI-BamHl-restriction-endonuclease fragment of EB15 (see Figure 2) . The sizes of transcripts encoding the rat InsP3 3-kinase B are 6 kb (indicated by an arrow). (e) expression of GAPDH. Abbreviations: T, total RNA (approx. 20 ,ug); A, poly(A) mRNA (approx. 4 ,g). The migration of RNA size markers is shown on the left. a 6 kb mRNA in HL-60 and HTB-138 cells. In SH-SY5Y cells the same probe recognized a doublet of 5.7-6.0 kb. In rat tissues, no signal was observed with the human InsP3 3-kinase B probe. When the same blot was hybridized with a rat InsP3 3-kinase B probe, a 6 kb mRNA signal was observed in rat tissues, but there was no signal in the human cell lines (Figure 4d) . Hybridization of the same blot with a GAPDH probe is shown in Figure 4 (e). (Takazawa et al., 1991a,b) . More recently, the rat orthologue of InsP3 3-kinase B was isolated from a rat liver cDNA library (Thomas et al., 1994) . We have found a nearly identical coding sequence after the screening of a rat thymus cDNA library and have provided evidence of InsP3 3-kinase activity when this clone (EB1 5) was expressed in Escherichia coli. From the screening of a human hippocampus cDNA library, we have obtained a new sequence (hvl R) identical with the hh3 MBI clone (Takazawa et al., 1991b) but containing a longer 5'-end coding sequence. We have also provided evidence that this clone gave rise to InsP3 3-kinase activity when expressed in E. coli.
In the present study we have isolated mRNA from several rat tissues and human cell lines and we have addressed the question of tissue-or cell-specific expression of InsP3 3-kinase A and B.
We have previously reported the presence, in rat thymus, of a 100 kDa isoenzyme. However, we were unable to demonstrate, by immunodetection, immunoprecipitation or activity assay after SDS/PAGE, the presence of InsP3 3-kinase A in rat thymus extracts (D'Santos et al., 1994) . Consistent with this, the Northern-blot analysis presented here has revealed that a probe designed in the 5' end of the rat InsP3 3-kinase B (i.e. a sequence presenting no significant sequence similarity to the 5' end of the rat InsP3 3-kinase A) hybridized specifically with a 6 kb mRNA in rat thymus. This result appeared to be specific for InsP3 3-kinase B, since an InsP3 3-kinase A probe did not show any hybridization signal in rat thymus. With other rat tissues (brain, testis, spleen, liver, kidney, heart, lung and intestine), no signal could be detected with an InsP3 3-kinase A probe, except in brain and testis (Table 2) . Moreover, isoenzyme B was predominantly expressed in lung and also in brain, thymus, testis and heart. These data therefore suggested that mRNAs encoding the two InsP3 3-kinase isoenzymes, A and B, were expressed in a tissuespecific manner: the isoenzyme A was specifically expressed in brain and testis, whereas the isoenzyme B was predominantly expressed in lung and also in thymus, heart, testis and brain. In some tissues no transcript could be detected with either probe. Assay of InsP3 3-kinase activity in spleen, liver, kidney and intestine crude soluble fractions indicated that this pathway is present in these cells. The absence of any signal (by Northernblot analysis) could be due to a very low expression level of the transcript or to the presence of another predominant isoenzyme. A previously unidentified isoenzyme is suggested by the cloning of a cDNA from a screening of a human thyroid cDNA library (K. Takazawa, personal communication) . Our data are comparable with the expression of various isoforms of the InsP3 receptor, which also indicated differential tissue localization and therefore heterogeneity of InsP3 action. Northern-blot hybridization of human haematopoietic-and lymphoma-cell lines revealed that the type I receptor was expressed relatively weakly in human haematopoietic and lymphoma cells, except in THP-I monocytes. In contrast, the type II receptor was expressed in large amounts in HL-60, Namalwa KJM-1 cells and Jurkat cells (YamamotoHino et al., 1994 What are the possible mechanisms that may change InsP3 3-kinase activities? Ca2+/CaM stimulation appears to be a quite general mechanism of control for various isoenzymes, but this varies depending on the tissue source and species. Rat brain isoenzyme A was stimulated 2-3-fold (Takazawa et al., 1990) , rat thymus and human lymphocyte isoenzymes were stimulated 4-6-fold and 10-fold respectively (D'Santos et al., 1994) and human platelet isoenzyme was stimulated 17-fold . This probably results from the existence of isoenzymes and non-conserved sequences in their regulatory domain. It is possible that this mechanism of stimulation of InsP4 production will occur in cells possessing a well defined isoenzyme, either to antagonize a physiological process regulated by InsP3 or alternatively to produce the potential InsP4 signal. For example, the tissue-specific expression ofCa2+/CaM-sensitive cyclic nucleotide phosphodiesterase isoforms is well defined. They also differ in their abilities to be stimulated by Ca2+/CaM, and this mechanism may, in some cells, antagonize cyclic AMP-regulated processes (Sonnenberg et al., 1993) .
Another mechanism of regulation of InsP3 3-kinase activity is its phosphorylation by protein kinase C. An inhibitory effect of phosphorylation by protein kinase C has been shown for the rat brain isoenzyme A and involved the simultaneous phosphorylation of two major sites: serine-1l9 and serine-185 ). Serine-i 19 is conserved in the sequence of both InsP3 3-kinase A and B from rat (Ser-1 19 in rat InsP3 3-kinase A and Ser-326 in rat InsP3 3-kinase B) and human (Ser-121 in human InsP3 3-kinase A and Ser-228 in human InsP3 3-kinase B); however, serine-185 (in rat InsP3) is not. It is therefore possible that the phosphorylation of InsP3 3-kinase by protein kinase C is only seen in tissues specifically expressing isoenzyme A. Other mechanisms of negative regulation of InsP3 3-kinase activity could be triggered by Ca2+ and calpain in rat brain (Lee et al., 1990) .
The tissue-specific expression of a given isoenzyme of InsP3 3-kinase is perhaps comparable with the expression of several isoforms of the multifunctional Ca2+/CaM-dependent protein kinase (Nghiem et al., 1993) . In human T lymphocytes, an isoenzyme has been cloned which showed differences with the neuronal form in the variable domain adjacent to the C-terminal end of the CaM-binding site. Consequently, CaM affinity may be affected. As for InsP3 3-kinase isoenzymes, differential expression suggests that they have become specialized for different roles in multiple tissues.
